Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Stevens

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Biorxiv : the Preprint Server for Biology|June 25, 2024
Structures of Native Doublet Microtubules from <i>Trichomonas vaginalis</i> Reveal Parasite-Specific Proteins as Potential Drug TargetsAlexander Stevens, Saarang Kashyap, Ethan H Crofut, et al.
Multiple Sclerosis and Related Disorders|September 21, 2025
Effects of vascular disease risk factors on brain metabolism in multiple sclerosisJacob Perlman, Helen Wu, Allison Fryman, et al.
Toxicology|August 5, 2017
The current status of exposure-driven approaches for chemical safety assessment: A cross-sector perspectiveFiona Sewell, Manoj Aggarwal, Gerald Bachler, et al.
JACS Au|January 31, 2025
Native Mass Spectrometry Captures the Conformational Plasticity of Proteins with Low-Complexity DomainsHannah Osterholz, Alexander Stevens, Mia L Abramsson, et al.
Neurosurgery|April 7, 2007
The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot studyEdward A Neuwelt, Csanád G Várallyay, Sándor Manninger, et al.
Elife|October 12, 2022
Antiviral function and viral antagonism of the rapidly evolving dynein activating adaptor NINLDonté Alexander Stevens, Christopher Beierschmitt, Swetha Mahesula, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2004
Identification of 2,3-diaryl-pyrazolo[1,5-b]pyridazines as potent and selective cyclooxygenase-2 inhibitorsPaul Beswick, Sharon Bingham, Chas Bountra, et al.
Journal of Medicinal Chemistry|November 29, 2014
Optimization of sphingosine-1-phosphate-1 receptor agonists: effects of acidic, basic, and zwitterionic chemotypes on pharmacokinetic and pharmacodynamic profilesJohn Skidmore, Jag Heer, Christopher N Johnson, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 2, 2004
The cyclooxygenase-2 inhibitor GW406381X [2-(4-ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine] is effective in animal models of neuropathic pain and central sensitizationSharon Bingham, Paul J Beswick, Chas Bountra, et al.
Science (New York, N.Y.)|July 2, 2026
Membrane protein solubilization and structure determination using de novo-designed proteinsLjubica Mihaljević, David E Kim, Pooja D Bandawane, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Biorxiv : the Preprint Server for Biology|June 25, 2024
Structures of Native Doublet Microtubules from <i>Trichomonas vaginalis</i> Reveal Parasite-Specific Proteins as Potential Drug TargetsAlexander Stevens, Saarang Kashyap, Ethan H Crofut, et al.
Multiple Sclerosis and Related Disorders|September 21, 2025
Effects of vascular disease risk factors on brain metabolism in multiple sclerosisJacob Perlman, Helen Wu, Allison Fryman, et al.
Toxicology|August 5, 2017
The current status of exposure-driven approaches for chemical safety assessment: A cross-sector perspectiveFiona Sewell, Manoj Aggarwal, Gerald Bachler, et al.
JACS Au|January 31, 2025
Native Mass Spectrometry Captures the Conformational Plasticity of Proteins with Low-Complexity DomainsHannah Osterholz, Alexander Stevens, Mia L Abramsson, et al.
Neurosurgery|April 7, 2007
The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot studyEdward A Neuwelt, Csanád G Várallyay, Sándor Manninger, et al.
Elife|October 12, 2022
Antiviral function and viral antagonism of the rapidly evolving dynein activating adaptor NINLDonté Alexander Stevens, Christopher Beierschmitt, Swetha Mahesula, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2004
Identification of 2,3-diaryl-pyrazolo[1,5-b]pyridazines as potent and selective cyclooxygenase-2 inhibitorsPaul Beswick, Sharon Bingham, Chas Bountra, et al.
Journal of Medicinal Chemistry|November 29, 2014
Optimization of sphingosine-1-phosphate-1 receptor agonists: effects of acidic, basic, and zwitterionic chemotypes on pharmacokinetic and pharmacodynamic profilesJohn Skidmore, Jag Heer, Christopher N Johnson, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 2, 2004
The cyclooxygenase-2 inhibitor GW406381X [2-(4-ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine] is effective in animal models of neuropathic pain and central sensitizationSharon Bingham, Paul J Beswick, Chas Bountra, et al.
Science (New York, N.Y.)|July 2, 2026
Membrane protein solubilization and structure determination using de novo-designed proteinsLjubica Mihaljević, David E Kim, Pooja D Bandawane, et al.
Pageof 2